Page 5 - Binding Site News Today

In this application note,  Siemens Healthineers shows how its N Latex FLC methods demonstrate good clinical concordance with The Binding Site FREELITE assay, with few discrepant results.

In this article, we discuss the top 10 dividend stock picks of elite hedge funds.

Thermo Fisher Scientific (NYSE: TMO), the supplier of scientific instrumentation, announced on Monday that it will acquire The Binding Site Group, a specialty diagn...

Expands specialty diagnostics segment with industry leader in oncology testing for detection and monitoring of multiple myeloma

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing Specialty Diagnostics Offering with Established

Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.

/PRNewswire/ -- Nordic Capital and Five Arrows have entered into a definitive agreement to sell The Binding Site, a global leader in specialty diagnostics, to...

(2022-10-31 | NYSE:TMO) Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a global leader in specialty diagnostics, from a shareholder group led by European private equity ...

The company is acquiring The Binding Site Group from private equity firm Nordic Capital.